BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3916593)

  • 1. Salivary lipids in health and disease.
    Slomiany BL; Murty VL; Slomiany A
    Prog Lipid Res; 1985; 24(4):311-24. PubMed ID: 3916593
    [No Abstract]   [Full Text] [Related]  

  • 2. Salivary lipids: A review.
    Matczuk J; Żendzian-Piotrowska M; Maciejczyk M; Kurek K
    Adv Clin Exp Med; 2017 Sep; 26(6):1021-1029. PubMed ID: 29068606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome.
    Porola P; Virkki L; Przybyla BD; Laine M; Patterson TA; Pihakari A; Konttinen YT
    J Rheumatol; 2008 Nov; 35(11):2229-35. PubMed ID: 18843777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary β2-microglobulin positively correlates with ESSPRI in patients with primary Sjögren's syndrome.
    Garza-García F; Delgado-García G; Garza-Elizondo M; Ceceñas-Falcón LÁ; Galarza-Delgado D; Riega-Torres J
    Rev Bras Reumatol Engl Ed; 2017; 57(2):182-184. PubMed ID: 28343624
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of human minor salivary glands in basic and applied secretion research.
    Izutsu KT; Schubert MM; Truelove EL; Johnson DE
    J Dent Res; 1987 Feb; 66 Spec No():654-9. PubMed ID: 3476630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
    van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of salivary protein biomarkers of saliva secretion disorder in a primary Sjögren syndrome murine model.
    Liang P; Zhu W; Lan T; Tao Q
    J Pharm Biomed Anal; 2018 May; 154():252-262. PubMed ID: 29558726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced salivary secretion contributes more to changes in the oral microbiome of patients with primary Sjögren's syndrome than underlying disease.
    van der Meulen TA; Harmsen HJM; Bootsma H; Liefers SC; Vich Vila A; Zhernakova A; Weersma RK; Spijkervet FKL; Kroese FGM; Vissink A
    Ann Rheum Dis; 2018 Oct; 77(10):1542-1544. PubMed ID: 29572289
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactoferrin in Sjögren's syndrome.
    Konttinen YT; Kulomaa M; Malmström M; Kilpi A; Reitamo S
    Arthritis Rheum; 1984 Apr; 27(4):462-7. PubMed ID: 6370271
    [No Abstract]   [Full Text] [Related]  

  • 10. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
    Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic diagnosis of Sjögren's syndrome.
    Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
    Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between salivary secretion and salivary AQP5 levels in health and disease.
    Wang D; Iwata F; Muraguchi M; Ooga K; Ohmoto Y; Takai M; Mori T; Ishikawa Y
    J Med Invest; 2009; 56 Suppl():350-3. PubMed ID: 20224222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection.
    Toussirot E; Le Huédé G; Mougin C; Balblanc JC; Bettinger D; Wendling D
    J Rheumatol; 2002 Nov; 29(11):2382-5. PubMed ID: 12415596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialochemistry in diseases and clinical situations affecting salivary glands.
    Mandel ID
    Crit Rev Clin Lab Sci; 1980; 12(4):321-66. PubMed ID: 7002465
    [No Abstract]   [Full Text] [Related]  

  • 16. VIP in salivary glands in Sjögren's syndrome.
    Törnwall J; Konttinen YT; Hietanen J; Sorsa T; Hukkanen M; Uusitalo H
    Br J Rheumatol; 1995 Sep; 34(9):891-3. PubMed ID: 7582736
    [No Abstract]   [Full Text] [Related]  

  • 17. Histochemical study of labial salivary glands in Sjögren's syndrome.
    Fava-De-Moraes F; Friedman H; Egami MI; Bevilacqua EM; Cossermelli W
    J Oral Pathol; 1978 Jun; 7(3):135-42. PubMed ID: 98631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in the salivary glands of Sjögren's syndrome patients in relation to tissue infiltration and lymphoepithelial lesions.
    Ferraccioli GF; De Vita S
    Arthritis Rheum; 1997 May; 40(5):987-90. PubMed ID: 9153568
    [No Abstract]   [Full Text] [Related]  

  • 19. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.
    Delaleu N; Mydel P; Kwee I; Brun JG; Jonsson MV; Jonsson R
    Arthritis Rheumatol; 2015 Apr; 67(4):1084-95. PubMed ID: 25545990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialochemical markers of salivary gland involvement with Sjögren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis.
    Carpenter GH; Proctor GB; Pankhurst CL; O'Donohue J; Scott D; Hunnable MP
    J Oral Pathol Med; 2000 Oct; 29(9):452-9. PubMed ID: 11016688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.